BI 638683

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 638683, covering 2011-06-02 to 2011-06-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of BI 638683 After Single Rising Oral Doses in Healthy Male Subjects [Phase 1]